2013 annual financial data
Karyopharm Therapeutics 2013 Operating margin
Karyopharm Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was -8,772.61%.
Operating income was -33,950,000 USD and net income was -33,947,000 USD.
Operating cash flow was -30,290,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 387,000 USD
- Operating income
- -33,950,000 USD
- Net income
- -33,947,000 USD
- Operating cash flow
- -30,290,000 USD